Halozyme Therapeutics HALO
NASDAQ HALO
$124.54 -0.29 (-0.23%)
At close: Oct 22, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Long-Term Debt Issuances (2016 - 2022)

Updated

Halozyme Therapeutics' Long-Term Debt Issuances came in at $1.47 billion for FY2025.

Analysis

Halozyme Therapeutics (HALO) Long-Term Debt Issuances (2016 - 2022) Analysis & Trends

Going back to FY2012, Halozyme Therapeutics' Long-Term Debt Issuances data covers 7 years.

  • Long-Term Debt Issuances carries a four-year compound annual growth rate of 17.0% (FY2021 to FY2025).
  • The FY2025 figure represents the highest annual Long-Term Debt Issuances in data going back to FY2012.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $702 million in FY2022 (-10.6%) and $784.88 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Halozyme Therapeutics 14.20 Bn 12.81 Bn 401.83 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 702.00 Mn
Jun 30, 2022 370.00 Mn
Dec 31, 2016 1,000.00
Jun 30, 2016 54.96 Mn
Mar 31, 2016 148.05 Mn
API Access

Halozyme Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=HALO&period=max&api_key=YOUR_API_KEY